Vestal Point Capital, LP Prime Medicine, Inc. Transaction History

Vestal Point Capital, LP

  • $1.32 Trillion
  • Q3 2024

A detailed history of Vestal Point Capital, LP transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 1,070,000 shares of PRME stock, worth $3.42 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
1,070,000
Previous 450,000 137.78%
Holding current value
$3.42 Million
Previous $2.31 Billion 79.03%
% of portfolio
0.31%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.41 - $6.7 $2.11 Million - $4.15 Million
620,000 Added 137.78%
1,070,000 $4.14 Billion
Q2 2024

Aug 14, 2024
BUY
$4.3 - $8.03 $387,000 - $722,700
90,000 Added 25.0%
450,000 $2.31 Billion
Q1 2024

May 13, 2024
BUY
$6.35 - $9.39 $2.16 Million - $3.19 Million
339,694 Added 1672.88%
360,000 $2.52 Billion
Q4 2023

Feb 13, 2024
BUY
$5.59 - $9.55 $113,510 - $193,922
20,306 New
20,306 $180 Million

Others Institutions Holding PRME

# of Institutions
123
Shares Held
64.7M
Call Options Held
324K
Put Options Held
64.4K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $306M
More about PRME
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email